In human PDAC tissue, DCLK1 immunostaining indicated that DCLK1 expression was higher in the stromal cells than that in tumor epithelial cells, suggesting a potential conversion to mesenchymal cells during the early tumorigenic process. Here, DCLK1 is linked to neoplasm.